A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease

<p><strong>Background</strong></p> Depression affects approximately 27% of adults with chronic kidney disease (CKD) and end-stage kidney failure (ESKF). Depression in this population is associated with impaired quality of life and increased mortality. The extent of inflammati...

全面介绍

书目详细资料
Main Authors: Jayakumar, S, Jennings, S, Halvorsrud, K, Clesse, C, Magdi Yaqoob. M, de Carvalho, LA, Bhui, K
格式: Journal article
语言:English
出版: Cambridge University Press 2022
_version_ 1826311098350960640
author Jayakumar, S
Jennings, S
Halvorsrud, K
Clesse, C
Magdi Yaqoob. M
de Carvalho, LA
Bhui, K
author_facet Jayakumar, S
Jennings, S
Halvorsrud, K
Clesse, C
Magdi Yaqoob. M
de Carvalho, LA
Bhui, K
author_sort Jayakumar, S
collection OXFORD
description <p><strong>Background</strong></p> Depression affects approximately 27% of adults with chronic kidney disease (CKD) and end-stage kidney failure (ESKF). Depression in this population is associated with impaired quality of life and increased mortality. The extent of inflammation and the impact on depression in CKD/ESKF is yet to be established. Through a systematic literature review and meta-analysis, we aim to understand the relationship between depression and inflammation in CKD/ESKF patients. <p><strong>Methods</strong></p> We searched nine electronic databases for published studies until January 2022. Titles and abstracts were screened against inclusion and exclusion criteria. Data extraction and study quality assessment was carried out independently by two reviewers. A meta-analysis was carried out where appropriate; otherwise a narrative review of studies was completed. <p><strong>Results</strong></p> Sixty studies met our inclusion criteria and entered the review (9481 patients included in meta-analysis). Meta-analysis of cross-sectional associations revealed significantly higher levels of pro-inflammatory biomarkers; C-reactive protein; Interleukin 6 (IL-6) and tumour necrosis factor-alpha in patients with depressive symptoms (DS) compared to patients without DS. Significantly lower levels of anti-inflammatory cytokine IL-10 were found in patients with DS compared to patients without DS. Considerable heterogeneity was detected in the analysis for most inflammatory markers. <p><strong>Conclusion</strong></p> We found evidence for an association of higher levels of pro-inflammatory and lower anti-inflammatory cytokines and DS in patients with CKD/ESKF. Clinical trials are needed to investigate whether anti-inflammatory therapies will be effective in the prevention and treatment of DS in these patients with multiple comorbidities.
first_indexed 2024-03-07T08:03:21Z
format Journal article
id oxford-uuid:40a60839-e9fa-4ccb-bc94-f34aa3ca0a29
institution University of Oxford
language English
last_indexed 2024-03-07T08:03:21Z
publishDate 2022
publisher Cambridge University Press
record_format dspace
spelling oxford-uuid:40a60839-e9fa-4ccb-bc94-f34aa3ca0a292023-10-17T08:30:22ZA systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney diseaseJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:40a60839-e9fa-4ccb-bc94-f34aa3ca0a29EnglishSymplectic ElementsCambridge University Press2022Jayakumar, SJennings, SHalvorsrud, KClesse, CMagdi Yaqoob. Mde Carvalho, LABhui, K<p><strong>Background</strong></p> Depression affects approximately 27% of adults with chronic kidney disease (CKD) and end-stage kidney failure (ESKF). Depression in this population is associated with impaired quality of life and increased mortality. The extent of inflammation and the impact on depression in CKD/ESKF is yet to be established. Through a systematic literature review and meta-analysis, we aim to understand the relationship between depression and inflammation in CKD/ESKF patients. <p><strong>Methods</strong></p> We searched nine electronic databases for published studies until January 2022. Titles and abstracts were screened against inclusion and exclusion criteria. Data extraction and study quality assessment was carried out independently by two reviewers. A meta-analysis was carried out where appropriate; otherwise a narrative review of studies was completed. <p><strong>Results</strong></p> Sixty studies met our inclusion criteria and entered the review (9481 patients included in meta-analysis). Meta-analysis of cross-sectional associations revealed significantly higher levels of pro-inflammatory biomarkers; C-reactive protein; Interleukin 6 (IL-6) and tumour necrosis factor-alpha in patients with depressive symptoms (DS) compared to patients without DS. Significantly lower levels of anti-inflammatory cytokine IL-10 were found in patients with DS compared to patients without DS. Considerable heterogeneity was detected in the analysis for most inflammatory markers. <p><strong>Conclusion</strong></p> We found evidence for an association of higher levels of pro-inflammatory and lower anti-inflammatory cytokines and DS in patients with CKD/ESKF. Clinical trials are needed to investigate whether anti-inflammatory therapies will be effective in the prevention and treatment of DS in these patients with multiple comorbidities.
spellingShingle Jayakumar, S
Jennings, S
Halvorsrud, K
Clesse, C
Magdi Yaqoob. M
de Carvalho, LA
Bhui, K
A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease
title A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease
title_full A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease
title_fullStr A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease
title_full_unstemmed A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease
title_short A systematic review and meta-analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end-stage kidney disease
title_sort systematic review and meta analysis of the evidence on inflammation in depressive illness and symptoms in chronic and end stage kidney disease
work_keys_str_mv AT jayakumars asystematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT jenningss asystematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT halvorsrudk asystematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT clessec asystematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT magdiyaqoobm asystematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT decarvalhola asystematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT bhuik asystematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT jayakumars systematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT jenningss systematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT halvorsrudk systematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT clessec systematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT magdiyaqoobm systematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT decarvalhola systematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease
AT bhuik systematicreviewandmetaanalysisoftheevidenceoninflammationindepressiveillnessandsymptomsinchronicandendstagekidneydisease